Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
Sweden · Delayed Price · Currency is SEK 399.80
+4.00 (1.01%)
At close: Feb 10, 2026
STO:SOBI Market Cap
STO:SOBI has a market cap or net worth of 136.81 billion as of February 10, 2026. Its market cap has increased by 17.04% in one year.
Market Cap
136.81B
Enterprise Value
147.27B
Revenue
28.24B
Ranking
n/a
PE Ratio
288.91
Stock Price
399.80
Market Cap Chart
Since September 15, 2006, STO:SOBI's market cap has increased from 4.83B to 136.81B, an increase of 2,733.59%. That is a compound annual growth rate of 18.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 136.81B | 19.28% |
| Dec 30, 2025 | 114.70B | 4.06% |
| Dec 30, 2024 | 110.22B | 20.19% |
| Dec 29, 2023 | 91.70B | 41.80% |
| Dec 30, 2022 | 64.67B | 16.86% |
| Dec 30, 2021 | 55.34B | 12.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 11.05B |
| Cereno Scientific AB | 2.10B |
| EQL Pharma AB | 1.82B |
| Orexo AB | 976.50M |
| Cinclus Pharma Holding AB | 784.63M |
| Dicot Pharma AB | 661.07M |
| Nanexa AB | 592.66M |
| Enzymatica AB | 449.06M |